基于深度学习的全自动腹部CT生物标志物用于2型糖尿病诊断
本研究在8992例接受CT结肠成像筛查的患者中,采用全自动深度学习方法分割胰腺并提取CT衰减、体积、脂肪含量及分形维数等生物标志物,结合内脏脂肪、动脉粥样硬化斑块、肝肌CT衰减等指标分析2型糖尿病。结果显示糖尿病患者胰腺CT衰减更低、内脏脂肪体积更大,最终多变量模型区分有无糖尿病的AUC为0.81和0.85,加入临床数据未改善CT模型性能。
要点
- 糖尿病患者胰腺CT衰减平均18.74 HU,低于非糖尿病患者的29.99 HU,且随病程延长呈进行性下降。
- 深度学习胰腺分割Dice系数0.69±0.17,与观察者间Dice系数0.69±0.09相似(P=.92)。
- 最终多变量模型区分无糖尿病与CT前0-2499天诊断糖尿病、CT后诊断糖尿病的AUC分别为0.81和0.85。
核心结论
- 2型糖尿病诊断与腹部CT生物标志物相关,尤其是胰腺CT衰减和内脏脂肪指标。
研究设计与样本
- 回顾性收集2004至2016年连续接受CT结肠成像结直肠癌筛查患者的非增强腹部CT用于外部验证,测试集共8992例(平均年龄57岁±8,女性5009例),其中572例患2型糖尿病;采用深度学习方法分割胰腺并输出CT衰减、体积、脂肪含量和胰腺分形维数,另评估内脏脂肪、动脉粥样硬化斑块、肝和肌肉CT衰减及肌肉体积;行单变量和多变量分析,按2型糖尿病诊断与CT检查日期间隔分组,并纳入性别、年龄、BMI、BMI大于30 kg/m2和身高,用多项逻辑回归确定最佳预测因子集。
关键影像表现/征象
- 糖尿病患者胰腺CT衰减平均18.74 HU±16.54,非糖尿病患者平均29.99 HU±13.41(P<.0001)。
- 糖尿病患者内脏脂肪体积平均235.0 mL±108.6,非糖尿病患者平均130.9 mL±96.3(P<.0001)。
- 糖尿病患者胰腺衰减随病程延长呈进行性下降。
诊断标准与关键数值
- 深度学习模型胰腺分割平均Dice相似系数0.69±0.17,观察者间Dice相似系数0.69±0.09(P=.92)。
- 最终多变量模型区分无糖尿病与CT前0-2499天诊断糖尿病患者AUC为0.81。
- 最终多变量模型区分无糖尿病与CT后诊断糖尿病患者AUC为0.85。
- 仅CT模型AUC=0.67,CT加临床数据模型AUC=0.68。
- 最佳预测因子包括胰腺内脂肪百分比、胰腺分形维数、L1至L4椎体水平斑块严重程度、平均肝脏CT衰减和BMI。
临床应用与阅片要点
- 阅片时可关注胰腺CT衰减降低和内脏脂肪体积增大,这些指标与2型糖尿病诊断相关。
- 全自动深度学习胰腺分割性能与观察者间一致性相似,可用于标准化提取胰腺CT生物标志物。
- 加入临床数据未改善CT模型对2型糖尿病的区分性能(AUC=0.67 vs 0.68)。
局限性
- 既往研究受手动方法和小样本量限制,本研究采用全自动深度学习和大型临床数据集。
- 原文未报告本研究自身的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background CT biomarkers both inside and outside the pancreas can potentially be used to diagnose type 2 diabetes mellitus. Previous studies on this topic have shown significant results but were limited by manual methods and small study samples. Purpose To investigate abdominal CT biomarkers for type 2 diabetes mellitus in a large clinical data set using fully automated deep learning. Materials and Methods For external validation, noncontrast abdominal CT images were retrospectively collected from consecutive patients who underwent routine colorectal cancer screening with CT colonography from 2004 to 2016. The pancreas was segmented using a deep learning method that outputs measurements of interest, including CT attenuation, volume, fat content, and pancreas fractal dimension. Additional biomarkers assessed included visceral fat, atherosclerotic plaque, liver and muscle CT attenuation, and muscle volume. Univariable and multivariable analyses were performed, separating patients into groups based on time between type 2 diabetes diagnosis and CT date and including clinical factors such as sex, age, body mass index (BMI), BMI greater than 30 kg/m2, and height. The best set of predictors for type 2 diabetes were determined using multinomial logistic regression. Results A total of 8992 patients (mean age, 57 years ± 8 [SD]; 5009 women) were evaluated in the test set, of whom 572 had type 2 diabetes mellitus. The deep learning model had a mean Dice similarity coefficient for the pancreas of 0.69 ± 0.17, similar to the interobserver Dice similarity coefficient of 0.69 ± 0.09 (P = .92). The univariable analysis showed that patients with diabetes had, on average, lower pancreatic CT attenuation (mean, 18.74 HU ± 16.54 vs 29.99 HU ± 13.41; P < .0001) and greater visceral fat volume (mean, 235.0 mL ± 108.6 vs 130.9 mL ± 96.3; P < .0001) than those without diabetes. Patients with diabetes also showed a progressive decrease in pancreatic attenuation with greater duration of disease. The final multivariable model showed pairwise areas under the receiver operating characteristic curve (AUCs) of 0.81 and 0.85 between patients without and patients with diabetes who were diagnosed 0-2499 days before and after undergoing CT, respectively. In the multivariable analysis, adding clinical data did not improve upon CT-based AUC performance (AUC = 0.67 for the CT-only model vs 0.68 for the CT and clinical model). The best predictors of type 2 diabetes mellitus included intrapancreatic fat percentage, pancreatic fractal dimension, plaque severity between the L1 and L4 vertebra levels, average liver CT attenuation, and BMI. Conclusion The diagnosis of type 2 diabetes mellitus was associated with abdominal CT biomarkers, especially measures of pancreatic CT attenuation and visceral fat. © RSNA, 2022 Online supplemental material is available for this article.
引用
- Tallam, Elton, Lee, et al. Fully Automated Abdominal CT Biomarkers for Type 2 Diabetes Using Deep Learning. Radiology. 2022. PMID: 35380492. doi:10.1148/radiol.211914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。